GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (FRA:CBHD) » Definitions » E10

Coloplast AS (FRA:CBHD) E10 : €2.74 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Coloplast AS E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Coloplast AS's adjusted earnings per share data for the three months ended in Dec. 2024 was €0.621. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €2.74 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Coloplast AS's average E10 Growth Rate was 6.20% per year. During the past 3 years, the average E10 Growth Rate was 9.20% per year. During the past 5 years, the average E10 Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Coloplast AS was 13.30% per year. The lowest was 8.20% per year. And the median was 11.20% per year.

As of today (2025-03-04), Coloplast AS's current stock price is €103.00. Coloplast AS's E10 for the quarter that ended in Dec. 2024 was €2.74. Coloplast AS's Shiller PE Ratio of today is 37.59.

During the past 13 years, the highest Shiller PE Ratio of Coloplast AS was 84.59. The lowest was 36.47. And the median was 55.77.


Coloplast AS E10 Historical Data

The historical data trend for Coloplast AS's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS E10 Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.90 2.11 2.38 2.58 2.73

Coloplast AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.58 2.64 2.70 2.73 2.74

Competitive Comparison of Coloplast AS's E10

For the Medical Instruments & Supplies subindustry, Coloplast AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Shiller PE Ratio falls into.



Coloplast AS E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Coloplast AS's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.621/118.9000*118.9000
=0.621

Current CPI (Dec. 2024) = 118.9000.

Coloplast AS Quarterly Data

per share eps CPI Adj_EPS
201503 0.512 100.200 0.608
201506 0.445 100.300 0.528
201509 -0.896 100.200 -1.063
201512 0.518 99.800 0.617
201603 0.578 100.200 0.686
201606 0.618 100.600 0.730
201609 0.268 100.200 0.318
201612 0.600 100.300 0.711
201703 0.589 101.200 0.692
201706 0.577 101.200 0.678
201709 0.637 101.800 0.744
201712 0.594 101.300 0.697
201803 0.580 101.700 0.678
201806 0.600 102.300 0.697
201809 0.655 102.400 0.761
201812 0.625 102.100 0.728
201903 0.640 102.900 0.740
201906 0.672 102.900 0.776
201909 0.498 102.900 0.575
201912 0.685 102.900 0.792
202003 0.669 103.300 0.770
202006 0.626 103.200 0.721
202009 0.656 103.500 0.754
202012 0.716 103.400 0.823
202103 0.713 104.300 0.813
202106 0.791 105.000 0.896
202109 0.823 105.800 0.925
202112 0.761 106.600 0.849
202203 0.619 109.900 0.670
202206 0.814 113.600 0.852
202209 0.778 116.400 0.795
202212 0.714 115.900 0.732
202303 0.731 117.300 0.741
202306 0.803 116.400 0.820
202309 0.733 117.400 0.742
202312 0.723 116.700 0.737
202403 0.747 118.400 0.750
202406 0.758 118.500 0.761
202409 0.783 118.900 0.783
202412 0.621 118.900 0.621

Add all the adjusted EPS together and divide 10 will get our e10.


Coloplast AS  (FRA:CBHD) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Coloplast AS's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=103.00/2.74
=37.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Coloplast AS was 84.59. The lowest was 36.47. And the median was 55.77.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Coloplast AS E10 Related Terms

Thank you for viewing the detailed overview of Coloplast AS's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

No Headlines